Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
22.64
+0.57 (2.56%)
Dec 20, 2024, 4:00 PM EST - Market closed
Neurogene Market Cap
Neurogene has a market cap or net worth of $335.72 million as of December 20, 2024. Its market cap has increased by 896.20% in one year.
Market Cap
335.72M
Enterprise Value
209.85M
1-Year Change
896.20%
Ranking
Category
Stock Price
$22.64
Market Cap Chart
Since March 7, 2014, Neurogene's market cap has increased from $114.10M to $335.72M, an increase of 194.23%. That is a compound annual growth rate of 10.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 336.30M | 639.12% |
| Dec 29, 2023 | 45.50M | 109.68% |
| Dec 30, 2022 | 21.70M | -89.39% |
| Dec 31, 2021 | 204.50M | -65.38% |
| Dec 31, 2020 | 590.70M | 25.07% |
| Dec 31, 2019 | 472.30M | 829.72% |
| Dec 31, 2018 | 50.80M | -81.59% |
| Dec 29, 2017 | 275.90M | -28.65% |
| Dec 30, 2016 | 386.70M | 80.03% |
| Dec 31, 2015 | 214.80M | 167.83% |
| Dec 31, 2014 | 80.20M | -29.71% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Absci | 335.38M |
| Spok Holdings | 333.68M |
| NeuroPace | 332.51M |
| Aquestive Therapeutics | 331.89M |
| Olema Pharmaceuticals | 331.52M |
| Corvus Pharmaceuticals | 327.07M |
| Candel Therapeutics | 323.46M |
| Acelyrin | 323.05M |